Travis Von Keller, in Encino, CA - Behavior Analyst

Travis Von Keller, is a Behavior Analyst based in Encino, California. Travis Von Keller is licensed to practice in * (Not Available) (license number 1-21-47658) and her current practice location is 5435 Balboa Blvd Ste 202, Encino, California. She can be reached at her office (for appointments etc.) via phone at (310) 933-4499.

NPI number for Travis Von Keller is 1023516507 and her current mailing address is 5435 Balboa Blvd Ste 202, Encino, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023516507.

Contact Information

	Travis Von Keller,
	5435 Balboa Blvd Ste 202, Encino, CA 91316-1570
	(310) 933-4499
	Not Available

Healthcare Provider's Profile

Full Name	Travis Von Keller
Gender	Female
Speciality	Behavior Analyst
Location	5435 Balboa Blvd Ste 202, Encino, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1023516507
Provider Enumeration Date: 01/30/2018
Last Update Date: 04/05/2021

Medical Identifiers

Medical identifiers for Travis Von Keller such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023516507	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	(* (Not Available))	Secondary
103K00000X	Behavior Analyst	1-21-47658 (* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Travis Von Keller is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Travis Von Keller, 5435 Balboa Blvd Ste 202, Encino, CA 91316-1570 Ph: (310) 933-4499	Travis Von Keller, 5435 Balboa Blvd Ste 202, Encino, CA 91316-1570 Ph: (310) 933-4499

News Archive

Accuray's InCise MLC for CyberKnife M6 System now available outside the U.S.

Accuray Incorporated announced today that the InCise Multileaf Collimator (MLC) for the CyberKnife M6 System will now be available outside the United States in markets where it is approved for sale, in addition to the U.S. market where the InCise MLC was commercially launched in February 2015.

SARS-CoV-2 Omicron variant: What we know so far

On November 24, 2021, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant was first reported to the World Health Organization (WHO) from South Africa.

New approach for production of tissue culture scaffolds in 3-D arrangements

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in the journal Advanced Materials, allows the production of tissue culture scaffolds containing multiple structurally and chemically distinct layers using common laboratory reagents and materials.

UI Hospital receives Medtronic Foundation grant to coordinate Illinois Heart Rescue

The University of Illinois Hospital and Health Sciences System has received a $2.5 million grant from the Medtronic Foundation to coordinate Illinois Heart Rescue, an ambitious statewide all-volunteer effort to more than double survival from sudden cardiac arrests in Illinois.

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

Travis Von Keller, - Counselor in Encino, CA